Counterpoint Global
North America, New York, United States, New York
Description
Counterpoint Global is a fundamental equities team at Morgan Stanley focused on long-term investing.
Investor Profile
Counterpoint Global has backed more than 28 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 11% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Singapore, United Kingdom.
- Strong thematic focus on Software, Biotechnology, Artificial Intelligence (AI).
Stage Focus
- Post Ipo Equity (32%)
- Series C (21%)
- Series D (18%)
- Series F (7%)
- Series E (7%)
- Series I (4%)
- Series G (4%)
- Series H (4%)
- Series Unknown (4%)
Country Focus
- United States (86%)
- Singapore (4%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (4%)
- Israel (4%)
Industry Focus
- Software
- Biotechnology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Analytics
- Machine Learning
- Predictive Analytics
- Information Technology
- Health Care
- Digital Media
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
